The Future of Metabolic and Bariatric Surgery in the Glucagon-Like Peptide-1 Era: Has the Scalpel Become Obsolete?
Journal of Obesity & Metabolic Syndrome · 30.10.2026 · 35 (4) · 385-396
DOI: 10.7570/jomes26007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Obesity & Metabolic Syndrome, online erschienen am 08.10.2026. Verfasst von Paul Wong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of General and Gastrointestinal Surgery, Department of Surgery, Brigham and Women's Hospital and Mass General Brigham, Boston, MA, USA. Hauptthemen laut MEDLINE: Bariatric Surgery, Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Glucagon-Like Peptide 1. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of General and Gastrointestinal Surgery, Department of Surgery, Brigham and Women's Hospital and Mass General Brigham, Boston, MA, USA.
ORCID-Profile: Paul Wong, Abdelrahman Nimeri
Zitieren
APA
Wong, P., & Nimeri, A. (2026). The Future of Metabolic and Bariatric Surgery in the Glucagon-Like Peptide-1 Era: Has the Scalpel Become Obsolete?. Journal of Obesity & Metabolic Syndrome, 35(4), 385-396. https://doi.org/10.7570/jomes26007
Vancouver
Wong P, Nimeri A. The Future of Metabolic and Bariatric Surgery in the Glucagon-Like Peptide-1 Era: Has the Scalpel Become Obsolete?. Journal of Obesity & Metabolic Syndrome. 2026;35(4):385-396. doi:10.7570/jomes26007
BibTeX
@article{Wong2026,
author = {Wong, Paul and Nimeri, Abdelrahman},
title = {The Future of Metabolic and Bariatric Surgery in the Glucagon-Like Peptide-1 Era: Has the Scalpel Become Obsolete?},
journal = {Journal of Obesity & Metabolic Syndrome},
year = {2026},
volume = {35},
number = {4},
pages = {385--396},
doi = {10.7570/jomes26007}
}
EUVIMED